Follow

Submissions from 2024

PDF

AAPM WGTG51 Report 385: Addendum to the AAPM's TG-51 protocol for clinical reference dosimetry of high-energy electron beams, Stephan Davis

PDF

Technical note: Determination of CQ for a miniature x-ray source using a soft x-ray ionization chamber calibrated in NIST reference beam qualities, Stephan Davis

Pulmonary contusion with hemoptysis from lacrosse ball strike: A case report, John DeRosimo, John Candela, and Michael McDermott

PDF

Pulmonary contusion with hemoptysis from lacrosse ball strike: A case report, John DeRosimo, John Candela, and Michael McDermott

Vitiligo-like amelanotic melanoma in situ: A rare presentation, Uzma Farooq and Naiara Braghiroli

PDF

Vitiligo-like amelanotic melanoma in situ: A rare presentation, Uzma Farooq and Naiara Braghiroli

SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

PDF

Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha

Survival outcomes of small cell variant bladder cancer: Analysis from a nationwide study, Mohammad Ganiyani, Saba Ahmad, Muni Rubens, Mukesh Roy, Bruno Bastos, Manuel Ozambela Jr, and Murugesan Manoharan

Implications of HPV infection on survival outcomes in patients with penile squamous cell carcinoma: Insights from a nationwide study, Mohammad Ganiyani, Diya Jayram, and Manmeet Ahluwalia

Socioeconomic disparities in survival outcomes of patients with NSCLC with brain metastases: A real-world analysis., Mohammad Ganiyani, Ahmad Ozair, Diya Jayram, and Manmeet Ahluwalia

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

PDF

Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer, Rohan Garje

Dissecting the Significance of Acid Phosphatase 1 Gene Alterations in Prostate Cancer, Rohan Garje

PDF

DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes, Rohan Garje

PDF

Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial), Rohan Garje

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Rohan Garje and Bruno Bastos

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Jerry George, Ranjini Tolakanahalli, Santiago Aguirre, Taehyung Kim, and Vivek Mishra

Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Jerry George, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong

PDF

Corrigendum: A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry, Siju George, Ranjini Tolakanahalli, Santiago Aguirre, and Vivek Mishra

A Review of Immunotherapy for Head and Neck Cancer, Jeffrey Goetz, Noah Kalman, and Alessandro Villa

PDF

Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma, Lauren Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits, and Noah Kalman

Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez and Eduardo Pons

PDF

Patient-specific quality assurance of dynamically-collimated proton therapy treatment plans, Alonso Gutierrez, Eduardo Pons, and Andrew Wroe

PDF

Proton Pencil Beam Scanning Facilitates the Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry, Matthew Hall

PDF

Weight Loss, Pathological Changes, and Inflammatory Effects from a Short-Term Ketogenic Diet in Overweight and Obese Men with Untreated Prostate Cancer on Active Surveillance, Adeel Kaiser

PDF

Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press

PDF

In Regard to Youssef et al, Noah Kalman and Sreenija Yarlagadda

PDF

Utility of TTMV-HPV DNA in resolving indeterminate findings during oropharyngeal cancer surveillance, Noah Kalman and Sreenija Yarlagadda

PDF

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021, Atulya Khosla

PDF

Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study, Atulya Khosla, Khurram Nasir, Anshul Saxena, Theodore Feldman, Jonathan Fialkow, Harneet Walia, Javier Valero-Elizondo, and Shozab Ali

PDF

Establishing Updated Safety Standards for Independent (99)(m)Tc-MAA SPECT/CT Treatment Planning in Radioembolization, Taehyung Kim, Ripal Gandhi, Ranjini Tolakanahalli, Raul Herrera, Michael Chuong, Alonso Gutierrez, and Diane Alvarez

PDF

Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study, Guenther Koehne

PDF

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial, Rupesh Kotecha

Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma, Rupesh Kotecha

PDF

Repeat Single-Session Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Systematic Review, Meta-Analysis, and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

PDF

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines, Rupesh Kotecha

PDF

Stereotactic Radiosurgery for Intermediate (III) or High (IV-V) Spetzler-Martin Grade Arteriovenous Malformations: International Stereotactic Radiosurgery Society Practice Guideline, Rupesh Kotecha

Stereotactic Radiosurgery for Intracranial Cavernous Malformations: International Stereotactic Radiosurgery Society, Systematic Review, Meta-Analysis, and Practice Guidelines, Rupesh Kotecha

PDF

Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study, Rupesh Kotecha and Manmeet Ahluwalia

PDF

How proton therapy fits into the management of adult intracranial tumors, Rupesh Kotecha, Alonso La Rosa De Los Rios, and Minesh Mehta

PDF

In Regard to Trifiletti et al, Rupesh Kotecha and Minesh Mehta

PDF

Multidisciplinary Management of Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary Molecularly Defined Era, Rupesh Kotecha and Minesh Mehta

A Phase I/II Study to assess safety and preliminary evidence of a therapeutic effect of azeliragon combined with stereotactic radiation therapy in patients with brain metasteses, Rupesh Kotecha, Yazmin Odia, Zhijian Chen, Amy K. Starosciak, Alonso La Rosa de los Rios, Susana Herrera, Miguel Ramirez Menendez, Cristina Pow-Sang, Suyen Ramos, Jennifer Perez, Manmeet Ahluwalia, and Minesh Mehta

Stereotactic Body Radiotherapy for liver metastases: Systematic review and meta-analysis with International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha and Zhenwei Zhang

Implementation Strategies to Promote Short-Course Radiation for Bone Metastases, Rahul Kumar and Joseph Panoff

PDF

Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun

PDF

Incidence and outcomes of postoperative fluid collections after minimally invasive distal pancreatectomy without placement of surgical drain. A prospective observational cohort study, Filipe Kunzler, Domenech Asbun, Ramon Jimenez, and Horacio Asbun

PDF

Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide, Tugce Kutuk

PDF

Emerging potential of tumor treating fields as a treatment modality for pancreatic cancer: a narrative review of therapeutic evolution, Tugce Kutuk, Adeel Kaiser, and Michael Chuong

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso LaRosa, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

PDF

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

PDF

Surgically targeted radiation therapy versus stereotactic radiation therapy: A dosimetric comparison for brain metastasis resection cavities, Tugce Kutuk, Rupesh Kotecha, Raul Herrera, D Jay Wieczorek, Zachary Fellows, Vibha Chaswal, Alonso La Rosa De Los Rios, Vivek Mishra, Michael McDermott, Vitaly Siomin, Minesh Mehta, Alonso Gutierrez, and Ranjini Tolakanahalli

PDF

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, and Noah Kalman

PDF

Interdisciplinary Collaboration in Head and Neck Cancer Care: Optimizing Oral Health Management for Patients Undergoing Radiation Therapy, Tugce Kutuk, Alessandro Villa, Noah Kalman, and Adeel Kaiser

PDF

Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis, Tugce Kutuk, Yanjia Zhang, Eyub Akdemir, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Alonso La Rosa De Los Rios, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Robert Press

PDF

Initial feasibility cohort of temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade intracranial malignancies, Alonso LaRosa, Zachary Fellows, Andrew Wroe, Len Coutinho, Eduardo Pons, Nicole McAllister, Ranjini Tolakanahalli, Tugce Kutuk, Matthew Hall, Robert Press, Michael McDermott, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, Alonso Gutierrez, and Rupesh Kotecha

PDF

Accelerated Hypofractionated Magnetic Resonance Guided Adaptive Radiation Therapy for Ultracentral Lung Tumors, Alonso La Rosa de los Rios, Kathryn Mittauer, Nema Bassiri-Gharb, Amy Rzepczynski, Michael Chuong, Sreenija Yarlagadda, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

PDF

Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha

PDF

A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using (125)I COMS plaques, Cecilia Lee

OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL, Yuliya Linhares

PDF

Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan, Nuria Lluis Vinas and Horacio Asbun

Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions, Arun Maharaj and Manmeet Ahluwalia

PDF

Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions, Arun Maharaj and Manmeet Ahluwalia

HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani

Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani

PDF

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer, Reshma Mahtani

PDF

The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results, Reshma Mahtani

PDF

Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series, Reshma Mahtani and Natasha Harpalani

Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia

Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia

PDF

Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement, Murugesan Manoharan and Jorge Caso

PDF

A Machine Learning Approach To Predict Mortality Due To Immune-Mediated Thrombotic Thrombocytopenic Purpura, Camila Masias

A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura, Camila Masias Castanon

PDF

Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe

PDF

A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults, Minesh Mehta

Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825, Minesh Mehta

PDF

Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Metastases: NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial, Minesh Mehta

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology, Minesh Mehta

PDF

DNA damage response in brain tumors: A Society for Neuro-Oncology consensus review on mechanisms and translational efforts in neuro-oncology, Minesh Mehta

PDF

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001, Minesh Mehta

PDF

Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001, Minesh Mehta

PDF

Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614, Minesh Mehta

Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice, Minesh Mehta

PDF

In Reply to Halperin, Minesh Mehta

NRG-BN002: Phase I Study of Ipilimumab, Nivolumab, and the Combination in Patients with Newly Diagnosed GBM, Minesh Mehta

PDF

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta

PDF

Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach, Minesh Mehta

PDF

Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012 to 2021) From the National Association for Proton Therapy, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wild type and -mutant lower grade gliomas, Minesh Mehta

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta

PDF

The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta

PDF

Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections, Lourdes MenendezAlvarado, Alice Landayan, Kelsey Williams, Corey Frederick, Zhenwei Zhang, and Timothy Gauthier

PDF

Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections, Lourdes Menendez Alvarado, Alice Margulis Landayan, Kelsey Williams, Corey Frederick, Zhenwei Zhang, and Timothy Gauthier

PDF

Push/Pull Assignement Methodology, Danielle Miller

PDF

Commissioning Intracranial Stereotactic Radiosurgery for a Magnetic Resonance-Guided Radiation Therapy (MRgRT) System: MR-RT Localization and Dosimetric End-to-End Validation, Kathryn Mittauer, Ranjini Tolakanahalli, Rupesh Kotecha, Michael Chuong, Minesh Mehta, Alonso Gutierrez, and Nema Bassiri-Gharb